Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (111-120 of 283) with videos related to

Pageof 29
Sort By:
Clinical Lung Cancer|March 19, 2020
Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical ConsiderationsJae Baek, Dwight H Owen, Robert E Merritt, et al.
Cancer Cell|October 19, 2004
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesisLi Yang, Laura M DeBusk, Koari Fukuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597Vicki Keedy, Wei Wang, Joan Schiller, et al.
The Journal of Clinical Investigation|February 27, 2014
Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinomaMarcin Imielinski, Heidi Greulich, Bethany Kaplan, et al.
Cell Death & Disease|June 5, 2021
Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lungWalter Z Wang, Konstantin Shilo, Joseph M Amann, et al.
Cancer Research|August 22, 2015
Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant MesotheliomaTadaaki Yamada, Joseph M Amann, Koji Fukuda, et al.
Lung Cancer (Amsterdam, Netherlands)|March 26, 2020
Prognostic value and therapeutic implications of expanded molecular testing for resected early stage lung adenocarcinomaPeter J Kneuertz, David P Carbone, Desmond M D'Souza, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literatureBradford J Siegele, Konstantin Shilo, Bo H Chao, et al.
JTO Clinical and Research Reports|October 14, 2021
Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLCDaiki Ikarashi, Tamio Okimoto, Takehito Shukuya, et al.
Cancer Research|September 18, 2004
Combination therapy with conditionally replicating adenovirus and replication defective adenovirusChoon-Taek Lee, Kyung-Ho Park, Kiyoshi Yanagisawa, et al.
Pageof 29

Showing results (111-120 of 283) with videos related to

Sort By:
Pageof 29
Clinical Lung Cancer|March 19, 2020
Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical ConsiderationsJae Baek, Dwight H Owen, Robert E Merritt, et al.
Cancer Cell|October 19, 2004
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesisLi Yang, Laura M DeBusk, Koari Fukuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597Vicki Keedy, Wei Wang, Joan Schiller, et al.
The Journal of Clinical Investigation|February 27, 2014
Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinomaMarcin Imielinski, Heidi Greulich, Bethany Kaplan, et al.
Cell Death & Disease|June 5, 2021
Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lungWalter Z Wang, Konstantin Shilo, Joseph M Amann, et al.
Cancer Research|August 22, 2015
Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant MesotheliomaTadaaki Yamada, Joseph M Amann, Koji Fukuda, et al.
Lung Cancer (Amsterdam, Netherlands)|March 26, 2020
Prognostic value and therapeutic implications of expanded molecular testing for resected early stage lung adenocarcinomaPeter J Kneuertz, David P Carbone, Desmond M D'Souza, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literatureBradford J Siegele, Konstantin Shilo, Bo H Chao, et al.
JTO Clinical and Research Reports|October 14, 2021
Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLCDaiki Ikarashi, Tamio Okimoto, Takehito Shukuya, et al.
Cancer Research|September 18, 2004
Combination therapy with conditionally replicating adenovirus and replication defective adenovirusChoon-Taek Lee, Kyung-Ho Park, Kiyoshi Yanagisawa, et al.
Pageof 29